Pfizer Inc. (PFE)

業務介紹

輝瑞公司在全球範圍內發現、開發、製造、行銷、分銷和銷售生物醫藥產品。它提供各種治療領域的藥物和疫苗,包括心血管代謝和婦女健康領域的Premarin家族和Eliquis品牌;Ibrance、Xtandi、Sutent、Inlyta、Retacrit、Lorbrena和Braftovi品牌下的生物製劑、小分子、免疫療法和生物類似藥;以及Sulperazon、Medrol、Zavicefta、Zithromax、Vfend、Panzyga和Paxlovid品牌下的無菌注射和抗感染藥物以及口服COVID-19治療藥物。該公司還提供肺炎球菌疾病、腦膜炎球菌疾病、扁平疣腦炎和COVID-19等治療領域的藥物和疫苗,品牌包括Comirnaty/BNT162b2、Nimenrix、FSME/IMMUN-TicoVac、Trumenba和Prevnar家族;Xeljanz、Enbrel、Inflectra、Eucrisa/Staquis和Cibinqo品牌下的慢性免疫和炎症性疾病的生物類似藥;以及Vyndaqel/Vyndamax、BeneFIX和Genotropin品牌下的淀粉樣蛋白病、血友病和內分泌疾病。此外,該公司還從事合同製造業務。它為批發商、零售商、醫院、診所、政府機構、藥房和個人醫療機構以及疾病控制和預防中心提供服務。該公司與布里斯托-邁爾斯·斯奎布公司、Astellas Pharma US, Inc.、Myovant Sciences Ltd.、Akcea Therapeutics, Inc、默克KGaA、Valneva SE、BioNTech SE和Arvinas, Inc.有合作協議。輝瑞公司成立於1849年,總部位於紐約。



Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

公司網址

https://www.pfizer.com